Fingerprint
Dive into the research topics of 'Phase II study of bortezomib in combination with cyclophosphamide and rituximab for relapsed or refractory mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of bortezomib in combination with cyclophosphamide and rituximab for relapsed or refractory mantle cell lymphoma
Hun Ju Lee, Jorge E. Romaguera, Lei Feng, Aakash P. Desai, Liang Zhang, Michelle Fanale, Felipe Samaniego, Fredrick B. Hagemeister, Luis E. Fayad, Maria A. Rodriguez, Jeffrey L. Medeiros, Kimberly Hartig, Krystle Nomie, Makhdum Ahmed, Maria Badillo, Haige Ye, Yasuhiro Oki, Pei Lin, Loretta Nastoupil, Jason Westin
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations